{"count": 2, "results": [{"_id": "33915312", "pmid": 33915312, "title": "Amplifying effect of chronic lisinopril therapy on diastolic function and the angiotensin-(1-7) Axis by the G1 agonist in ovariectomized spontaneously hypertensive rats.", "journal": "Transl Res", "authors": ["Sun X", "Wang H", "Hodge H", "Wright KN", "Ahmad S", "Ferrario CM", "Groban L"], "date": "2021-09-01T00:00:00Z", "doi": "10.1016/j.trsl.2021.04.004", "meta_date_publication": "2021 Sep", "meta_volume": "235", "meta_issue": "", "meta_pages": "62-76", "score": 50255.387, "text_hl": "We conclude that activating @GENE_GPER1 @GENE_171104 @@@GPER@@@ with G1 augments components of the cardiac RAS and improves diastolic function without lowering blood pressure, and that @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@-induced blood pressure control and @<m>DISEASE_Heart_Neoplasms</m> @DISEASE_MESH:D006338 @@@cardiac alterations@@@ in OVX SHR are permissive in facilitating G1 to augment Ang-(1-7) in serum, thereby strengthening its cardioprotective benefits.", "citations": {"NLM": "Sun X, Wang H, Hodge H, Wright KN, Ahmad S, Ferrario CM, Groban L. Amplifying effect of chronic lisinopril therapy on diastolic function and the angiotensin-(1-7) Axis by the G1 agonist in ovariectomized spontaneously hypertensive rats. Transl Res. 2021 Sep;235():62-76. PMID: 33915312", "BibTeX": "@article{33915312, title={Amplifying effect of chronic lisinopril therapy on diastolic function and the angiotensin-(1-7) Axis by the G1 agonist in ovariectomized spontaneously hypertensive rats.}, author={Sun X and Wang H and Hodge H and Wright KN and Ahmad S and Ferrario CM and Groban L}, journal={Transl Res}, volume={235}, pages={62-76}}"}}, {"_id": "19344651", "pmid": 19344651, "title": "ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.", "journal": "Vascul Pharmacol", "authors": ["Sacco G", "Mario B", "Lopez G", "Evangelista S", "Manzini S", "Maggi CA"], "date": "2009-05-01T00:00:00Z", "doi": "10.1016/j.vph.2009.01.001", "meta_date_publication": "2009 May-Jun", "meta_volume": "50", "meta_issue": "5-6", "meta_pages": "166-70", "score": 50052.152, "text_hl": "Using dose levels (0.1 mg/kg/day and 10 mg/kg/day) which inhibits partially (about 50%) or almost totally (about 80%) serum @GENE_ACE @GENE_24310 @@@angiotensin converting enzyme@@@, we evaluated the effects of @CHEMICAL_zofenopril @CHEMICAL_MESH:C044958 @@@zofenopril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in preventing @<m>DISEASE_Heart_Neoplasms</m> @DISEASE_MESH:D006338 @@@cardiac alterations@@@ (@DISEASE_Long_QT_Syndrome @DISEASE_MESH:D008133 @@@QalphaT prolongation@@@) induced by chronic treatment with @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@ (1.5 mg/kg q7dx5 i.v.). ", "citations": {"NLM": "Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Vascul Pharmacol. 2009 May-Jun;50(5-6):166-70. PMID: 19344651", "BibTeX": "@article{19344651, title={ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.}, author={Sacco G and Mario B and Lopez G and Evangelista S and Manzini S and Maggi CA}, journal={Vascul Pharmacol}, volume={50}, number={5-6}, pages={166-70}}"}}]}